Why life-saving gene therapy isn’t available yet to children who need it most

dl belgium
[The first patient to permanently edit his DNA,] Brian Madeux, 44, of Arizona, is part of a clinical trial testing a gene-editing approach for Hunter syndrome, a type of metabolic disorder that slowly destroys the body’s cells. The life expectancy of people born with the disease is 10 to 20 years, so most patients are children. For now, the trial Madeux is enrolled in is only open to adults. So young patients who desperately need the therapy to survive will need to wait to get it.

The U.S. Food and Drug Administration often wants companies to show that a treatment is safe in adults before it can be used in children. Sangamo Therapeutics, the company conducting the trial, is aiming to treat nine adult patients before it can admit children into the current trial.

..

The Sangamo therapy uses a gene-editing technology called zinc finger nucleases rather than the newer CRISPR. It’s designed to insert a correct copy of the IDS gene into liver cells. Sangamo thinks this should enable the liver to produce a lifelong and stable supply of the enzyme the patient lacks.

[Hunter Syndrome Foundation founder Jeanette] Henriquez says that despite her optimism, she’d be reluctant to enroll her son in the trial if it became open to children, because gene editing comes with risks.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: A New Gene-Editing Therapy Would Benefit Kids Most – Here’s Why They Won’t Get It Yet

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-11-16-at-2.37.32-PM
30 years of GMO farming: Is the boom in glyphosate and glufosinate use harming the environment? Data show they’re the most sustainable choice
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-11-19-at-7.23.23-PM
Viewpoint: After a yearlong hiatus, the U.S. Preventive Services Task Force is back in business—gutted by RFK Jr. and promoting junk science
Stormlit Portrait Over Golden Mountains
Searching for life where no one thought to look: A renowned astrophysicist’s seemingly quixotic quest to explore Venus’s clouds
Soybean Harvest in Cupped Hands
30 years of GMO farming: Defying cynics, we’ve had larger harvests, lower costs, and $385 billion in added global farmer income
Screenshot-2026-11-19-at-7.54.57-PM
European General Court sides with scientists, dismisses activist claims that glyphosate is toxically dangerous
Nurturing Care Beneath the Crunchy Moms Logo
Crunchy Moms disinformation flood: Zuckerberg's Facebook has opened floodgates on measles and vaccines
Screenshot-2026-11-17-at-12.18.09-PM
Challenging glyphosate fear-mongering: Statewide Nebraska study finds no link between weedkiller use and non-Hodgkin lymphoma
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.